Loading compound...
Serotonin receptor agonist
Naluzotan is a small molecule drug currently being studied in clinical trials. It works as a serotonin 1a (5-HT1a) receptor agonist, which means it interacts with specific serotonin receptors in the brain. It is being investigated for its potential use in treating anxiety, major depressive disorder, and temporal lobe epilepsy.
How it worksNaluzotan acts on serotonin 1a (5-HT1a) receptors in the body.
Used for
AnxietyMajor depressive disorderTemporal lobe epilepsy
Conditions
AnxietyMajor depressive disorderTemporal lobe epilepsy
Class
Serotonin agonistSerotonin receptor agonistNervous system
How to take
Naluzotan is currently in the research and development phase (Phase 3) and is not yet widely available for general use.
Talk to your doctor
Questions to ask
- ·Is Naluzotan currently available in clinical trials?
- ·How does Naluzotan differ from other serotonin medications?
- ·What are the potential risks of serotonin 1a agonists?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
